KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Other Accumulated Expenses: 2009-2012

Historic Other Accumulated Expenses for Bausch Health Companies (BHC) over the last 4 years, with Dec 2012 value amounting to $109.4 million.

  • Bausch Health Companies' Other Accumulated Expenses rose 127.78% to $109.4 million in Q4 2012 from the same period last year, while for Dec 2012 it was $109.4 million, marking a year-over-year increase of 127.78%. This contributed to the annual value of $109.4 million for FY2012, which is 127.78% up from last year.
  • Per Bausch Health Companies' latest filing, its Other Accumulated Expenses stood at $109.4 million for FY2012, which was up 127.78% from $48.0 million recorded in FY2011.
  • Bausch Health Companies' Other Accumulated Expenses' 5-year high stood at $109.4 million during FY2012, with a 5-year trough of $8.0 million in FY2009.
  • For the 3-year period, Bausch Health Companies' Other Accumulated Expenses averaged around $72.2 million, with its median value being $59.2 million (2010).
  • Per our database at Business Quant, Bausch Health Companies' Other Accumulated Expenses soared by 644.84% in 2010 and then declined by 18.88% in 2011.
  • Bausch Health Companies' Other Accumulated Expenses (Yearly) stood at $8.0 million in 2009, then spiked by 644.84% to $59.2 million in 2010, then decreased by 18.88% to $48.0 million in 2011, then spiked by 127.78% to $109.4 million in 2012.